Julianne Teresa Djordjevic

16PUBLICATIONS
19CO-AUTHORS
Medical infection agents (incl. prions)Characterisation of biological macromoleculesProteins and peptidesCheminformatics and quantitative structure-activity relationshipsInfectious agents
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Feb 17, 2026
The cyclin dependent kinase (CDK)7 inhibitor BS-181 inhibits pathogenic Cryptococcus species, causing G2/M arrest and a splicing defect.

Pooja Sethiya, Desmarini Desmarini, Bethany Bowring

|Oct 31, 2025
Functional insight into cyclin-dependent kinase (CDK)7 via chemical inhibition of the priority fungal pathogen Cryptococcus neoformans.

Pooja Sethiya, Desmarini Desmarini, Bethany Grace Bowring

|Jul 25, 2025
Design, Synthesis, and Cellular Characterization of a New Class of IPMK Kinase Inhibitors.

Yubai Zhou, Pratima Chapagain, Desmarini Desmarini

|Mar 31, 2025
Synthesis of a New Purine Analogue Class with Antifungal Activity and Improved Potency against Fungal IP3-4K.

Desmarini Desmarini, Daniel Truong, Pooja Sethiya

|May 14, 2024
Arg1 from Cryptococcus neoformans lacks PI3 kinase activity and conveys virulence roles via its IP3-4 kinase activity.

Desmarini Desmarini, Guizhen Liu, Henning Jessen

|Apr 05, 2023
Dysregulating PHO Signaling via the CDK Machinery Differentially Impacts Energy Metabolism, Calcineurin Signaling, and Virulence in Cryptococcus neoformans.

Bethany Grace Bowring, Pooja Sethiya, Desmarini Desmarini

Pageof 3

Frequent Collaborators

6 joint publications

Sophie Lev

3 joint publications

Philip E Thompson

2 joint publications

Tania C Sorrell

2 joint publications

Amy K Cain